The effect of antifibrotic agents on acute respiratory failure in COVID-19 patients: a retrospective cohort study from TriNetX US collaborative networks

The effect of antifibrotic agents on acute respiratory failure in COVID-19 patients: a retrospective cohort study from TriNetX US collaborative networks

Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has had a significant impact on global health and economies, resulting in millions of infections and deaths. This retrospective cohort study aimed to investigate the effect of antifibrotic agents (nintedanib and pirfenidone) on 1-y...

Full description

Bibliographic Details
Main Authors: Hsin-Yi Wang, Shih-Chuan Tsai, Yi-Ching Lin, Jing-Uei Hou, Chih-Hao Chao
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Pulmonary Medicine
Subjects:
Antifibrotic agent
Nintedanib
Pirfenidone
COVID-19
Acute respiratory failure
Mortality
Online Access:https://doi.org/10.1186/s12890-024-02947-5

Internet

https://doi.org/10.1186/s12890-024-02947-5

Similar Items